v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
 12 Months Ended 158 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
OPERATING ACTIVITIES      
Net loss $ (5,276,669) $ (2,075,128) $ (37,532,066)
Depreciation   309 52,694
Disposal of equipment   4,066 36,623
Stock-based compensation-product development costs     528,618
Stock-based compensation-interest expenses 2,408,193 546,619 7,953,077
Stock-based compensation-selling, general and admin 230,877 50,000 3,223,816
Stock-based compensation-professional fees 43,785 1,030 44,815
Other non-cash items included in net loss     294,020
Unpaid Interest expense on line of credit 215,553   215,553
Non-cash imputed interest expenses 179,261 183,738 2,997,828
Equity instruments issued to settle liabilities     1,871,718
Decrease in prepaid expenses (3,615) 42 (3,615)
Increase in accounts payable and accrued liabilities 57,109 (4,680) 1,371,724
Increase in advances payable (68,151) (52,368) 3,146,985
Increase in interest payable 504,401 501,977 3,776,877
Income tax receivable     8,727
Cash used in operating activities (1,709,255) (844,395) (12,012,604)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Other financing activities     (115,472)
Expenditures to repurchase shares     (342,038)
Proceeds from issuance of shares     1,512,403
Repayment of promissory notes payable     (970,879)
Proceeds from issuance of lines of credit 1,718,429 845,566 11,982,671
Net cash provided by financing activities 1,718,429 845,566 12,066,685
Net increase in cash 9,173 1,171 11,003
Cash, beginning of period 1,829 658  
Cash, end of period 11,002 1,829 11,002
Cash paid for interest   5,857 1,223,335
Interest expense incurred in connection with options granted in exchange for increase in borrowing limit on existing line of credit financing 1,493,702 546,619 1,493,702
Interest expense incurred in connection with options granted as compensation for receiving line of credit financing 914,491   6,459,375
Options exercised for reduction in advances payable $ 45,000   $ 45,000